Evidence map›Paper›PMID 36298850›Full record

ArticleViruses2022

Host-Level Susceptibility and IRF1 Expression Influence the Ability of IFN-γ to Inhibit KSHV Infection in B Lymphocytes.

Nedaa Alomari, Jennifer Totonchy

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nedaa AlomariBiomedical and Pharmaceutical Sciences, Chapman University, Irvine, CA 92618, USA.
Jennifer TotonchyBiomedical and Pharmaceutical Sciences, Chapman University, Irvine, CA 92618, USA.ORCID 0000-0002-8444-8536
Chapman University · US

Funding

Identifying susceptibility factors for KSHV infection in human tonsilR01CA239590 · NCI · CHAPMAN UNIVERSITY · PI TOTONCHY, JENNIFER E · 2019 to 2023
$1.7M
NCI NIH HHS R01 CA239590NCI NIH HHS R01CA239590
6 · The paper itself

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with vascular endothelial cell tumor, Kaposi's sarcoma (KS) and lymphoproliferative disorder, multicentric Castleman's disease (MCD), primary effusion lymphoma (PEL) and KSHV inflammatory cytokine syndrome (KICS). Dysregulation of proinflammatory cytokines is found in most KSHV associated diseases. However, little is known about the role of host microenvironment in the regulation of KSHV establishment in B cells. In the present study, we demonstrated that IFN-γ has a strong inhibitory effect on KSHV infection but only in a subset of tonsil-derived lymphocyte samples that are intrinsically more susceptible to infection, contain higher proportions of naïve B cells, and display increased levels of IRF1 and STAT1-pY701. The effect of IFN-γ in responsive samples was associated with increased frequencies of germinal center B cells (GCB) and decreased infection of plasma cells, suggesting that IFN-γ-mediated modulation of viral dynamics in GC can inhibit the establishment of KSHV infection.

Indexed as

B-LymphocytesHerpesviridae InfectionsHerpesvirus 8, HumanInterferon-gammaAcquired Immunodeficiency SyndromeCastleman DiseaseCytokinesDisease SusceptibilityHumansInterferon Regulatory Factor-1Sarcoma, KaposiTumor MicroenvironmentCytokinesInterferon-gammaInterferon Regulatory Factor-1IRF1 protein, humanB lymphocyteHHV-8KSHVtype II interferon signaling

Identifiers

PMID36298850
PMCPMC9607942
OpenAlexW4306948182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.